Nanobiosensors in Healthcare Market is Rising Prevalence of Chronic Disease along with Technological Advancement, is Projected to Boost Growth

Pune, India, June 2021/MRFR Press Release/- Market Research Future has Published a Half-Cooked Research Report on the Global Nanobiosensors in Healthcare Market.

Market Highlights

The global Nanobiosensors in Healthcare Market is Expected to reach USD 798.41 Million by 2030 at 10.60% CAGR during the forecast period (2022–2030).

The nanobiosensors are advance analytical devices used to detect the chemical and biological substance and helps to understand and analyze the nature of the biological structure. nanobiosensors are the sensors that are made up of nanomaterials and have dimensions between 1 to 100 nanometers. The increasing prevalence of diabetes, advancement in monitoring systems, and raising awareness about advance nanobiosensors are expected to drive the growth of the market during the forecast period. For Instance, According to the report published by World Health Organization(WHO) in 2016, diabetes is a major healthcare concern in Brazil, and it affected more than 8.1% of the population, the prevalence of diabetes was more in females, and it affected more than 8.8% females in the country.

However, high costs involved in research and development and unwillingness toward the adoption of new treatment practices hinder the growth of the market during the forecast period.

Segmentation

The global nanobiosensors in healthcare market has been segmented on the basis of type, application, end user, and region.

On the basis of type, the market has been classified as optical nanobiosensor, electrochemical nanobiosensor, acoustic nanobiosensor, and others. The electrochemical nanobiosensor segment is expected to hold the largest market share of the nanobiosensors in healthcare market owing to its high sensitivity and real-time detection features. Based on the application, the market has been segmented into diabetes, immunoassay, cancer, pathogenic bacteria, and others. The market, by end user, has been divided into as hospitals and clinics, diagnostic centers, point of care, and others. However, based on end user point of care testing segment holds the largest market share due to low complex infrastructure and training.

Key Players

Some of the prominent key players in the global nanobiosensors in healthcare market are Abbott Point of Care, Inc., F. Hoffman-LA Roche Ltd., Medtronic Inc., Nano-Proprietary, Inc., Lifescan, Inc., Illuminex Corporation, Lifesensors, Inc., ACON Laboratories, Inc., Pharmaco-Kinesis Corporation, Bayer Healthcare AG, Bio-Rad Laboratories, Inc., Biosensors International Pte. Ltd., Sysmex Corporation.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Nanobiosensors in Healthcare Market Research Report

Regional Analysis

The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The nanobiosensors in healthcare market in the Americas has further been segmented into North America and South America, with the North America market further classified into the US and Canada.

The European nanobiosensors in healthcare market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 

The nanobiosensors in healthcare market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The nanobiosensors in healthcare market in the Middle East & Africa has been segmented into the Middle East and Africa.